← Leaderboards
Wajahat Zafar Mehal
Va Connecticut Healthcare System
$6,608,431
Attributed
$8,159,231
Total exposure
13
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,159,231 · 11
VA$0 · 2
By mechanism
U01$3,142,953 · 2
R01$2,446,467 · 2
P30$940,168 · 2
K08$656,370 · 1
R56$333,000 · 1
R21$253,383 · 1
Top collaborators
- Robert F. Schwabe5 shared
- Richard A Flavell2 shared
- Albert F Candia1 shared
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverHepatocytePathway InteractionsCellsMolecularTissuesLiver DiseasesProductionResponseReceptorInflammatoryHepaticBaseMitochondrial DnaInjuryInflammationGrantSignal TransductionMortalityLigandsIn VivoSterilityMouse ModelCytokine
Grant awards (43)
Non-parenchymalcells drive the key features of alcohol associated hepatitis (AAH) in a fully humanized mouse liver$688,199
R01 · FY2025 · AA
Explore the role of hepatocyte inflammasome in alcoholic liver disease$253,383
R21 · FY2025 · AA
P and F Program$188,034
P30 · FY2025 · DK · contact PI
Regulation of Liver Fibrosis by Pyruvate Kinase M2 (PKM2)$0
I01 · FY2025 · VA · contact PI
P and F Program$188,032
P30 · FY2024 · DK · contact PI
Regulation of Liver Fibrosis by Pyruvate Kinase M2 (PKM2)$0
I01 · FY2024 · VA · contact PI
P and F Program$188,034
P30 · FY2023 · DK · contact PI
Regulation of Liver Fibrosis by Pyruvate Kinase M2 (PKM2)$0
I01 · FY2023 · VA · contact PI
Inhibition of Sterile Inflammation by Digoxin in Alcoholic Hepatitis$232,656
U01 · FY2022 · AA · contact PI
P and F Program$188,034
P30 · FY2022 · DK · contact PI
Regulation of Liver Fibrosis by Pyruvate Kinase M2 (PKM2)$0
I01 · FY2022 · VA · contact PI
Inhibition of Sterile Inflammation by Digoxin in Alcoholic Hepatitis$236,778
U01 · FY2021 · AA · contact PI
P and F Program$188,034
P30 · FY2021 · DK · contact PI
Inhibition of Sterile Inflammation by Digoxin in Alcoholic Hepatitis$241,342
U01 · FY2020 · AA · contact PI
Cell-free DNA is a driver of non-alcoholic steatohepatitis via TLR9 activation$0
I01 · FY2020 · VA · contact PI
Inhibition of Sterile Inflammation by Digoxin in Alcoholic Hepatitis$245,550
U01 · FY2019 · AA · contact PI
Cell-free DNA is a driver of non-alcoholic steatohepatitis via TLR9 activation$0
I01 · FY2019 · VA · contact PI
Inhibition of Sterile Inflammation by Digoxin in Alcoholic Hepatitis$249,999
U01 · FY2018 · AA · contact PI
Cell-free DNA is a driver of non-alcoholic steatohepatitis via TLR9 activation$0
I01 · FY2018 · VA · contact PI
Targeting DAMPs in Alcoholic Hepatitis$372,541
U01 · FY2017 · AA
Cell-free DNA is a driver of non-alcoholic steatohepatitis via TLR9 activation$0
I01 · FY2017 · VA · contact PI
Targeting DAMPs in Alcoholic Hepatitis$381,019
U01 · FY2016 · AA
Targeting DAMPs in Alcoholic Hepatitis$377,574
U01 · FY2015 · AA
Targeting DAMPs in Alcoholic Hepatitis$385,324
U01 · FY2014 · AA
Targeting DAMPs in Alcoholic Hepatitis$420,170
U01 · FY2013 · AA
Regulation of Hepatic Repair Response by Metabolites of the Uric Acid Pathway$333,000
R56 · FY2013 · DK · contact PI
The Development of TLR Antagonists for Therapy of Hepatic Fibrosis and Cirrhosis$223,390
R41 · FY2013 · DK
Sterile Hepatic Inflammation$0
I01 · FY2012 · VA · contact PI
Regulation of hepatic repair responses by metabolites of the uric acid pathway$325,873
R01 · FY2011 · DK · contact PI
Sterile Hepatic Inflammation$0
I01 · FY2011 · VA · contact PI
Sterile Hepatic Inflammation$0
I01 · FY2011 · VA · contact PI
Regulation of hepatic repair responses by metabolites of the uric acid pathway$329,165
R01 · FY2010 · DK · contact PI
Regulation of hepatic repair responses by metabolites of the uric acid pathway$332,490
R01 · FY2009 · DK · contact PI
Regulation of hepatic repair responses by metabolites of the uric acid pathway$100,000
R01 · FY2009 · DK · contact PI
Regulation of hepatic repair responses by metabolites of the uric acid pathway$332,490
R01 · FY2008 · DK · contact PI
Regulation of hepatic repair responses by metabolites of the uric acid pathway$338,250
R01 · FY2007 · DK · contact PI
HEPATIC TOLERIZATION OF THE CD8+ T CELL IMMUNE RESPONSE$132,975
K08 · FY2005 · DK
Kupffer cell mediated deletion of activated CD8+ T cells$81,750
R03 · FY2005 · DK
HEPATIC TOLERIZATION OF THE CD8+ T CELL IMMUNE RESPONSE$131,895
K08 · FY2004 · DK
Kupffer cell mediated deletion of activated CD8+ T cells$81,750
R03 · FY2004 · DK
HEPATIC TOLERIZATION OF THE CD8+ T CELL IMMUNE RESPONSE$132,300
K08 · FY2003 · DK
HEPATIC TOLERIZATION OF THE CD8+ T CELL IMMUNE RESPONSE$132,300
K08 · FY2002 · DK
HEPATIC TOLERIZATION OF THE CD8+ T CELL IMMUNE RESPONSE$126,900
K08 · FY2001 · DK